PD-1 gene rs10204525 and rs7421861 polymorphisms are associated with increased risk and clinical features of esophageal cancer in a Chinese Han population.

作者: Bao Zang , Chen Chen , Jian-Qiang Zhao

DOI: 10.18632/AGING.102845

关键词:

摘要: Programmed death-1 (PD-1) polymorphisms have been associated with esophageal cancer risk. Here, the aims of this case-control study were to explore whether three PD-1 (rs10204525, rs7421861, and rs36084323) related risk clinical features in Chinese Han subjects (n = 814 cases 961 controls). We found that rs10204525 but not rs36084323, conferred increased susceptibility cancer. Subgroup analysis revealed all loci among men, rs7421861 correlated patients ≥ 60 years old. The higher TNM stage, was distant metastasis. combination smoking either or genotype an cancer, which is indicative potential gene-environment interactions. gene protein levels, Kaplan-Meier survival curves showed expression poorer overall survival. These data indicate confer individuals.

参考文章(56)
Julia Liz, Manel Esteller, lncRNAs and microRNAs with a role in cancer development. Biochimica et Biophysica Acta. ,vol. 1859, pp. 169- 176 ,(2016) , 10.1016/J.BBAGRM.2015.06.015
Shuchen Chen, Mingqiang Kang, Haiyong Gu, Yu Chen, Bin Sun, Weifeng Tang, Programmed death-1 (PD-1) polymorphism is associated with gastric cardia adenocarcinoma. International Journal of Clinical and Experimental Medicine. ,vol. 8, pp. 8086- 8093 ,(2015)
Vahid Chaleshi, Hamid Asadzadeh Aghdaei, Pedram Azimzadeh, Ehsan Nazemalhosseini Mojarad, Sanaz Savabkar, Programmed death-1 gene polymorphism (PD-1.5 C/T) is associated with gastric cancer Gastroenterology and hepatology from bed to bench. ,vol. 6, pp. 178- 182 ,(2013) , 10.22037/GHFBB.V6I4.435
Y. Ishida, Y. Agata, K. Shibahara, T. Honjo, Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. The EMBO Journal. ,vol. 11, pp. 3887- 3895 ,(1992) , 10.1002/J.1460-2075.1992.TB05481.X
Yang Zhao, ZhiJun Dai, WeiLi Min, Xin Sui, HuaFeng Kang, YunFeng Zhang, Hong Ren, Xi Jing Wang, Perioperative Versus Preoperative Chemotherapy With Surgery in Patients With Resectable Squamous Cell Carcinoma of Esophagus: A Phase III Randomized Trial Journal of Thoracic Oncology. ,vol. 10, pp. 1349- 1356 ,(2015) , 10.1097/JTO.0000000000000612
W. B. Robb, M. Messager, L. Dahan, F. Mornex, E. Maillard, X. B. D'Journo, J.-P. Triboulet, L. Bedenne, J.-F. Seitz, C. Mariette, , Patterns of recurrence in early‐stage oesophageal cancer after chemoradiotherapy and surgery compared with surgery alone British Journal of Surgery. ,vol. 103, pp. 117- 125 ,(2015) , 10.1002/BJS.9959
Loise M. Francisco, Peter T. Sage, Arlene H. Sharpe, The PD-1 pathway in tolerance and autoimmunity Immunological Reviews. ,vol. 236, pp. 219- 242 ,(2010) , 10.1111/J.1600-065X.2010.00923.X
Lieping Chen, Xue Han, Anti–PD-1/PD-L1 therapy of human cancer: past, present, and future Journal of Clinical Investigation. ,vol. 125, pp. 3384- 3391 ,(2015) , 10.1172/JCI80011
Hao Qiu, Liang Zheng, Weifeng Tang, Pengfei Yin, Feng Cheng, Lixin Wang, Programmed death-1 (PD-1) polymorphisms in Chinese patients with esophageal cancer. Clinical Biochemistry. ,vol. 47, pp. 612- 617 ,(2014) , 10.1016/J.CLINBIOCHEM.2013.12.023
Rajeev Vibhakar, Gloria Juan, Frank Traganos, Zbigniew Darzynkiewicz, Lawrence R. Finger, Activation-Induced Expression of Human Programmed Death-1 Gene in T-Lymphocytes Experimental Cell Research. ,vol. 232, pp. 25- 28 ,(1997) , 10.1006/EXCR.1997.3493